Cerebras Enters Q3 Print at $93.66, 49% Below IPO Price

Cerebras closed at $93.66 on Tuesday, down 3.1 percent, one day before its Q3 2026 report. The stock now trades about 49 percent below its $185 IPO price. Morgan Stanley cut its target to $178 from $279 on 10 November, while keeping its Overweight rating, according to MarketBeat.

The company reports after the US close on Thursday 12 November. The call starts at 5 p.m. ET, 22:00 GMT. The main IPO lock-up expired on 9 November. That removes one overhang. It also removed insiders: MarketBeat reports insider sales of 1,924,452 shares worth about $394.6 million over the past 90 days.

What does the company guide for Q3?

Cerebras guided core revenue of $214 million to $216 million. Consensus from Zacks sits near the top at about $215.8 million, with a loss of 13 cents per share. The guide implies only modest growth. In Q2, the company reported GAAP revenue of $180.1 million and core revenue of about $209.9 million.

The margin guide matters more. Core gross margin guidance of 38 to 40 percent sits below Q2's 41 percent. In June, the stock fell 14 percent after its first report as a public company disappointed on full-year margin forecasts, according to Reuters. Margin guidance moved the stock last time. It likely will again.

The full-year guide is $880 million to $890 million in core revenue, raised in August from $855 million to $865 million, per Barchart. Any change here is the main signal for 2027. One analyst preview, from GuruFocus, expects a modest revenue beat and a higher guide, tied to OpenAI commitments and demand for faster inference.

Backlog is the number to watch. Remaining performance obligations stood at $25.4 billion as of 30 June. An update will show how much of the OpenAI commitment converts into revenue. That conversion remains unproven at scale.

What do the analysts say?

Most firms cut targets in the past month while keeping positive ratings. The cuts are steep:

• Morgan Stanley: $178, down from $279, on 10 November
• UBS: $250, down from $330, on 2 November
• TD Cowen: $175, down from $275, on 19 October
• Wedbush: $190, a $100 cut, Outperform kept
• Citi: $320, per Gotrade data
• Barclays: Buy, $280 target, per Barchart

The consensus target is $261.80 with a Moderate Buy rating, per MarketBeat. Even the lowest target sits far above the current price. These targets mostly reflect expectations for 2027 revenue, not Thursday's price action. The main bear case in circulation is a short report from Culper Research, disclosed on 28 October, per Barchart.

The 52-week range runs from $77.84 to $386.34. The low came on 5 November. The stock closed at $89.68 the next day and gained on 9 November, the day the main lock-up ended.

Where could the stock go after the print?

Reference levels measured from Tuesday's close: $110 above, $78 below. These are anchors, not forecasts. The bull case at $110 requires a revenue beat, another full-year guide raise, and backlog evidence that OpenAI demand is turning into sales. That move would mirror June's 14 percent fall in the other direction. The bear case at $78 anchors to the $77.84 intraday low of 5 November, about 17 percent below Tuesday's close. It triggers if margins or the full-year forecast disappoint. A base case of $88 to $100 assumes results land near the guide.

The source found no options-implied move from two independent sources. None is quoted here.

Up to about 171.1 million shares could be released over the full lock-up period, including up to 15 million held by directors and officers. That supply sits behind every rally attempt. The same AI spending question drives the sector this week: CoreWeave raised its 2026 revenue guide on Tuesday night, lifting chip stocks before Wednesday's open.

Next marker after Thursday: Nvidia reports on 17 November, the next major reading on AI chip demand.